Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell Lymphoma
Clinical trial NCT03719898 · WITHDRAWN
Trial details
- NCT number
- NCT03719898
- Sponsor
- Fox Chase Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2020-03-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.